Sarcos Robotics, a global leader in the production of robots that augment humans to enhance productivity and safety, has raised $40 million in an oversubscribed Series C financing round, bringing its total venture capital raised to nearly $100 million. The company plans to use the capital for marketing the Guardian XO industrial exoskeleton, scheduled for commercial release in 2021.
The Guardian XO exoskeleton, which has been under development for more than 20 years, is its first full-body, a battery-powered wearable industrial robot designed to increase strength and endurance. It can safely lift up to 200 pounds for extended work sessions and can operate for up to eight hours on a single charge.
Making full use of its 24 degrees of freedom, the Guardian XO’s hands-free mode allows the user to lock the arms of the suit and perform lifting movements. Redundant hardware and software support passive braking to prevent bodily injury.
This Guardian XO exoskeleton has been specially designed to help with human tasks that require heavy lifting. The aim is to increase the physical capacities of workers while reducing the risk of injury. The suit applies to a myriad of industries such as aviation, manufacturing, warehousing, logistics, oil & gas, construction, defense, and others.
“This new funding will allow us to achieve our next goal of scaling production and shipping commercial units of the Guardian XO exoskeleton. In addition, we will also advance the development of our ‘smart’ version of the Guardian XO exoskeleton with our Cybernetic Training for Autonomous Robots (CYTAR) artificial intelligence platform, which will enable the robot to augment the operator’s precision and skill to complete specific tasks,” said Ben Wolff, chairman and CEO, Sarcos Robotics.